- Advertisement -
- About 4% of the global population lives with an anxiety disorder, such as generalized anxiety disorder (GAD).
- While there are currently treatment options available for GAD, past studies show that about 50% of people will not respond to first-line treatments like antidepressant therapy.
- A new study reports the results of a phase 2b clinical trial of an LSD medication that shows promise in…

